IRIS
PUCCETTI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.499
EU - Europa 7.186
AS - Asia 4.105
SA - Sud America 634
AF - Africa 140
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 6
Totale 20.580
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.369
CN - Cina 1.536
GB - Regno Unito 1.508
RU - Federazione Russa 1.491
SG - Singapore 1.307
IE - Irlanda 960
IT - Italia 841
UA - Ucraina 592
SE - Svezia 567
BR - Brasile 528
FR - Francia 479
DE - Germania 332
HK - Hong Kong 318
VN - Vietnam 305
KR - Corea 226
FI - Finlandia 204
IN - India 93
CA - Canada 73
ZA - Sudafrica 66
TR - Turchia 51
BD - Bangladesh 41
IQ - Iraq 38
JP - Giappone 38
NL - Olanda 38
MX - Messico 35
AR - Argentina 27
ES - Italia 26
PL - Polonia 26
BE - Belgio 25
NG - Nigeria 25
PK - Pakistan 19
AT - Austria 17
CZ - Repubblica Ceca 16
ID - Indonesia 16
EC - Ecuador 15
CO - Colombia 14
MY - Malesia 14
VE - Venezuela 14
KE - Kenya 13
MA - Marocco 13
SA - Arabia Saudita 13
UZ - Uzbekistan 11
AU - Australia 9
CL - Cile 9
PH - Filippine 9
PY - Paraguay 8
RO - Romania 8
BO - Bolivia 7
CH - Svizzera 7
ET - Etiopia 7
LT - Lituania 7
PE - Perù 7
IL - Israele 6
JM - Giamaica 6
KG - Kirghizistan 6
KZ - Kazakistan 6
OM - Oman 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
DZ - Algeria 5
EU - Europa 5
HR - Croazia 5
JO - Giordania 5
PT - Portogallo 5
DO - Repubblica Dominicana 4
IR - Iran 4
UY - Uruguay 4
BG - Bulgaria 3
BN - Brunei Darussalam 3
CI - Costa d'Avorio 3
EG - Egitto 3
KH - Cambogia 3
LB - Libano 3
LK - Sri Lanka 3
LV - Lettonia 3
NI - Nicaragua 3
NP - Nepal 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
AZ - Azerbaigian 2
BH - Bahrain 2
CY - Cipro 2
GR - Grecia 2
HN - Honduras 2
IM - Isola di Man 2
MD - Moldavia 2
MT - Malta 2
NO - Norvegia 2
PS - Palestinian Territory 2
RS - Serbia 2
AM - Armenia 1
BY - Bielorussia 1
CM - Camerun 1
CU - Cuba 1
GE - Georgia 1
GI - Gibilterra 1
GY - Guiana 1
HU - Ungheria 1
IS - Islanda 1
Totale 20.565
Salva come PNG Salva come JPEG
Città #
Southend 1.305
Dallas 1.219
Dublin 959
Fairfield 842
Singapore 765
Ashburn 564
Chandler 469
Jacksonville 462
Santa Clara 433
Woodbridge 395
Moscow 375
Beijing 347
Wilmington 344
Houston 324
Seattle 311
Hong Kong 309
Hefei 301
Cambridge 248
San Jose 248
Seoul 224
Ann Arbor 223
Princeton 191
Nanjing 176
New York 166
The Dalles 143
Siena 129
Los Angeles 111
Lauterbourg 100
Ho Chi Minh City 93
Milan 91
Hanoi 81
Helsinki 78
San Mateo 77
Shanghai 71
Buffalo 67
Munich 64
Boardman 61
San Diego 59
Florence 57
Johannesburg 56
São Paulo 50
Council Bluffs 46
Nanchang 41
Hebei 37
Bengaluru 35
Tokyo 35
Changsha 34
Rome 34
Menlo Park 31
Turku 30
Columbus 29
Toronto 29
Chicago 26
Lancaster 26
London 26
Orem 26
Shenyang 26
Jiaxing 25
San Francisco 25
Dearborn 24
Tianjin 23
Brussels 22
Abuja 21
Nuremberg 19
Hangzhou 17
Kunming 17
Warsaw 17
Brooklyn 16
Düsseldorf 16
Frankfurt am Main 16
Guangzhou 16
Rio de Janeiro 16
Da Nang 15
Chennai 14
Denver 14
Haiphong 14
Jinan 14
Istanbul 13
Manchester 13
Montreal 13
Málaga 13
Ningbo 13
Baghdad 12
Brno 12
Norwalk 12
Stockholm 12
Washington 12
Belo Horizonte 11
Boston 11
Brasília 11
Grosseto 11
Izmir 11
Paris 11
Philadelphia 11
Redondo Beach 11
Vienna 11
Atlanta 10
Mexico City 10
Mumbai 10
Taizhou 10
Totale 13.724
Salva come PNG Salva come JPEG
Nome #
Potenziale endogeno di trombina (ETP) e parametri di screening della coagulazione. Comparazione tra INR, D-Dimero ed ETP in una popolazione di soggetti anticoagulati con Warfarin per fibrillazione atriale cronica. 390
Endogenous thrombin potential and screening parameters of coagulation [Potenziale endogeno di trombina e parametri di screening della coagulazione] 374
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 361
Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome 317
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 307
Neurohumoral improvement and torsional dynamics in patients with heart failure after treatment with levosimendan 301
Quantitative evaluation of microvessels in Behcet's disease 288
Residual peripheral blood CD26+leukemic stem cells in chronic myeloid leukemia patients during TKI therapy and during treatment-free remission 287
Atherothrombotic Risk and TKIs Treatment In Chronic Myeloid Leukemia Patients: A Role For Genetic Predisposition and Pro-Inflammatory/Pro-Oxidative Status? 285
Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function. 281
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients 276
Genetic influence in antithrombotic actions of atorvastatin in hypercholesterolaemia 270
Atherothrombotic risk assessment during tyrosine kinase inhibitors treatment in chronic myeloid leukemia patients: new insight? 267
Effect of two single oral doses of mesoglycan on the coagulative and fibrinolytic system in human. A pharmacodynamic study [Azione di due dosi orali singole di mesoglicano sul sistema coagulativo-fibrinolitico dell'uomo. Studio farmacodinamico] 256
Cytokines in acute coronary syndromes 255
Takayasu's arteritis: case report of a patient with recurrent subclavian steal syndrome 249
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may explain increased atherothrombotic risk during TKI treatment in chronic myeloid leukemia patients 243
Cardiac dysautonomia and arterial distensibility in essential hypertensives 241
Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients 239
Analisi morfometrica ultrastrutturale di piastrine e leucociti nel paziente sottoposto ad angioplastica coronarica e nell'arteriopatia obliterante periferica 238
Effects of fluoxetine treatment on carbohydrate metabolism in human blood platelets: a 1H-NMR study 237
Heart failure and chronic kidney disease in a registry of internal medicine wards 230
A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma 225
Effects of carvedilol therapy on restrictive diastolic filling pattern in chronic heart failure 220
Coagulative, fibrinolytic and metabolic pattern in patients with central retinal vein occlusion 220
Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects 218
A fatal unsuspected case of acquired A hemophilia. Misleading role of therapy with acetylsalicylic acid? 217
Long-Term use of ticagrelor in patients with prior myocardial infarction 216
Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure 215
Cardiac papillary fibroelastoma: An unusual source of cerebral embolism solved with local fibrinolysis 215
Definizione di pattern videocapillaroscopici (VCS) di normalità nel microcircolo cutaneo. Stratificazione secondo l'età 214
L’apoptosi linfocitaria nell’infarto miocardico acuto senza sopraelevazione del tratto ST 214
Lectin-like oxidized-LDL receptor-1 (LOX-1) polymorphisms influence cardiovascular events rate during statin treatment 212
Different effect of statins on platelet oxidized-LDL receptor (CD36 and LOX-1) expression in hypercholesterolemic subjects 211
Chronic urticaria and blastocystis hominis infection. A case report 208
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 207
Different mechanisms of fibrinolysis impairment among dyslipidemic subjects 199
Potenziale endogeno di trombina e parametri di screening della coagulazione. 199
Cranial osteolytic metastases as the only recurrence of gastric carcinoma 198
Genetic involvement in statins induced myopathy. Preliminary data from an observational case-control study 197
Plasma brain natriuretic peptide levels in coronary heart disease with preserved systolic function 196
Bosentan treatment on Raynaud Phenomenon and Skin Fibrosis in Patients with Systemic Sclerosis and with Pulmonary Arterial Hypertension: an open-label, observational, retrospective study 193
Dyslipidemias and fibrinolysis. 192
Genetic modulation of anti-inflammatory effects of atorvastatin; probably a multi-gene condition 191
Circadian rhythm during unfractioned heparin i.v.infusion in man: modification by ASA or pentoxifylline per os 188
Diurnal rhythm of the anticoagulant effect of continuous i.v. infusion of unfractioned heparin: a possible role for platelet activation 188
Different effect induced by treatment with statins on monocyte tissue factor expression in hypercholesterolemic subjects 187
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 186
Platelet hyperactivity after statin treatment discontinuation 184
Complement activation in hypercholesterolemia 184
Central Retinal Vein Occlusion and Prothrombotic Factors 184
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 184
Variazioni diurne dell’ effetto anticoagulante dell’ eparina non frazionata in corso di infusione continua e.v. nell’ uomo. Modificazioni indotte da acido acetlsalicico per os 182
Real-life experience of edoxaban treatment for venous thromboembolism (VTE)/pulmonary embolism (PE) in patients with isolated positive Lupus Anticoagulant (LAC) during the COVID-19 pandemic lockdown in Italy 180
Time-dependent effect of statins on platelet function in hypercholesterolaemia 179
Protective effects of novel metal-nonoates on the cellular components of the vascular system 178
In-hospital death according to dementia diagnosis in acutely ill elderly patients: the REPOSI study 177
Pharmacogenetics of statins therapy 177
Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study 175
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 175
Increased TNF-alpha production by peripheral blood mononuclear cells in patients with Krabbe's disease: effect of psychosine 174
Structural and functional abnormality of systemic microvessels in cardiac syndrome X 173
T cell activation and enhanced apoptosis in non-ST elevation myocardi infarction 171
Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series 169
In-hospital death and adverse clinical events in elderly patients according to disease clustering: the REPOSI study 169
Transmitral and pulmonary venous flow study in elite male runners and young adults 169
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 168
Circulating esRAGE is Associated with a Pro-Inflammatory/Pro-Atherothrombotic Profile in Familial Combined Hyperlipidemia Patients with Non-alcoholic Fatty Liver Disease 167
Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype 167
Levosimendan improves pro/anti-inflammatory cytokines imbalance in male patients with advanced heart failure. A randomized, double-blind, placebo-controlled study 165
Evidences of new risk factors for retinal vein thrombosis 164
Statins discontinuation in compliant chronic users induces atherothrombotic profile despite baseline clinical setting and treatments 161
Pro-inflammatory/anti-inflammatory cytokine imbalance in acute coronary syndromes 161
Systemic adenosine increase during cold pressor test is dependent on sympathetic activation 161
Genetics of the coenzyme Q10 pathway and rosuvastatin-induced muscle effects 159
Safety of long-term simvastatin discontinuation 158
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia 157
Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects 157
Diatolic filling in hypertrophied hearts of elite runners: an echo-doppler study 156
Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly 156
Microvascular assessment in Behcet disease: videocapillaroscopic study. 156
Genetic influence in statin intolerance 156
Role of platelets in tissue factor expression by monocytes in normal and hypercholesterolemic subjects. In vitro effect of cerivastatin 154
Role of genetic factors in statins side-effects 154
Psoriasis successfully treated with guselkumab in a patient with systemic lupus erythematosus and acquired hemophilia A 154
Mechanism for antiplatelet action of statins 149
Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards 146
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study) 146
Pro/anti-inflammatory cytokine imbalance in postischemic left ventricular remodeling 145
Variazioni diurne dell'effetto anticoagulante in corso di infusione continua e.v. di eparina non frazionata nell'uomo.Modificazioni indotte da acido acetilsalicilico per os. 144
Early anti-thrombotic and anti-inflammatory actions of statins and fibrates -: time for adjuvant therapy in acute coronary syndromes? 142
Effetto dell' acido acetilsalicilico e della pentossifillina sulle variazioni diurne dell' attività anticoagulante dell' eparina non frazionata somministrata per infusione continua endovenosa nell' uomo 141
Prospective Monitoring of Peripheral Blood CD26+ Leukemia Stem Cells in Chronic Myeloid Leukemia Patients from Time of TKI Discontinuation 133
Report of two cases of subconjunctival haemorrhage as first sign of post‐pregnancy acquired haemophilia a (AHA) 130
Refractory Takayasu arteritis successfully treated with infliximab 129
Relationship between serum complement and different lipid disorders 128
MEDICAL TREATMENT OF CRVO 128
New generation analysis of thrombin generation in retinal vein thrombosis 126
Peripheral Blood Flow-Cytometry Chronic Myeloid Leukemia Stem Cells Detection and Quantification during Tyrosine Kinase Inhibitors Therapy 125
Hypercoagulable state in hypercholesterolemic subjects assessed by platelet-dependent thrombin generation. In vitro effect of cerivastatin 118
Totale 19.763
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.343
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.343
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021345 0 0 0 0 0 0 0 0 0 124 138 83
2021/20221.328 104 162 94 161 70 22 63 36 59 128 122 307
2022/20231.842 112 147 274 234 172 373 33 156 186 30 97 28
2023/20241.531 57 36 123 74 53 464 501 34 16 39 41 93
2024/20252.848 66 142 286 146 372 142 52 147 233 114 336 812
2025/20266.526 529 993 1.018 801 1.363 281 734 198 261 348 0 0
Totale 20.691